These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6953619)

  • 1. Lack of association of HLA-DR antigens with progressive systemic sclerosis (scleroderma).
    Niks M; Rovenský J; Nyulassy S; Buc M; Stefanovic J; Zitnan D
    Tissue Antigens; 1982 Mar; 19(3):238-9. PubMed ID: 6953619
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-D antigens in progressive systemic sclerosis (scleroderma).
    DiBartolomeo AG; Rabin BS; Rodnan GP
    Immunol Commun; 1981; 10(8):733-40. PubMed ID: 6210624
    [No Abstract]   [Full Text] [Related]  

  • 3. DR antigens in systemic sclerosis: lack of clinical correlations.
    Alarcón GS; Phillips RM; Wasner CK; Acton RT; Barger BO
    Tissue Antigens; 1985 Aug; 26(2):156-8. PubMed ID: 3864290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, immunologic, and genetic features of familial systemic sclerosis.
    Assassi S; Arnett FC; Reveille JD; Gourh P; Mayes MD
    Arthritis Rheum; 2007 Jun; 56(6):2031-7. PubMed ID: 17530643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA-DR with progressive systemic sclerosis in Japanese.
    Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
    J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of HLA antigens with scleroderma].
    Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
    Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and scleroderma.
    Ercilla MG; Arriaga F; Gratacós MR; Coll J; Lecha V; Vives J; Castillo R
    Arch Dermatol Res; 1981; 271(4):381-5. PubMed ID: 6949497
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
    Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
    Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA antigens with progressive systemic sclerosis and morphea.
    Kühnl P; Sibrowski W; Boehm BO; Holzmann H; Sollberg S
    Tissue Antigens; 1989 Sep; 34(3):207-9. PubMed ID: 2595726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma).
    Clements PJ; Opelz G; Terasaki PI; Mickey MR; Furst D
    Tissue Antigens; 1978 Apr; 11(4):357-61. PubMed ID: 78536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microchimera. New thought process for pathogenesis of systemic scleroderma].
    Haustein UF
    Hautarzt; 2000 Feb; 51(2):59-62. PubMed ID: 10743573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma.
    Dunckley H; Jazwinska EC; Gatenby PA; Serjeantson SW
    Tissue Antigens; 1989 Mar; 33(3):418-20. PubMed ID: 2568026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of systemic sclerosis.
    Silman AJ; Newman J
    Curr Opin Rheumatol; 1996 Nov; 8(6):585-9. PubMed ID: 9018464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris].
    Volk HD; Diezel W; Waschke SR; Barthelmes H; Grunow R; Fiebig H; Sönnichsen N
    Dermatol Monatsschr; 1985; 171(5):308-11. PubMed ID: 3926547
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants.
    Manolios N; Dunckley H; Chivers T; Brooks P; Englert H
    J Rheumatol; 1995 Jan; 22(1):85-92. PubMed ID: 7699689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.